Sudden cardiac death and decompensation of heart failure: how to reduce the risks. A review

Sudden cardiac death and decompensation of heart failure: how to reduce the risks. A review

The main causes of death in patients with heart failure (HF) are sudden cardiac death and decompensation of HF, especially with a low left ventricular ejection fraction. The prediction and prevention of risk factors for the development of these conditions are important goals both for guideline-direc...

Full description

Saved in:

Bibliographic Details
Main Authors:	Marina V. Kuleshova, Tatiana M. Uskach, Oleg V. Sapelnikov
Format:	Article
Language:	Russian
Published:	"Consilium Medicum" Publishing house 2025-01-01
Series:	Терапевтический архив
Subjects:	sudden cardiac death implantable cardioverter defibrillator heart failure multisensory monitoring
Online Access:	https://ter-arkhiv.ru/0040-3660/article/viewFile/635246/175209
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

IMPLANTABLE CARDIOVERTER DEFIBRILLATORS ARE THE MAIN MODE FOR SUDDEN CARDIAC DEATH PREVENTION
by: L. A. Bokeria, et al.
Published: (2019-02-01)

Analysis of electrotherapy of cardioverter defibrillators implanted for the primary prevention of sudden cardiac death
by: V. K. Lebedeva, et al.
Published: (2019-08-01)

PREVENTION OF SUDDEN CARDIAC DEATH BY IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS: ANALYSIS OF LARGE-SCALE CLINICAL TRIALS AND RECOMMENDATIONS OF EUROPEAN SOCIETY OF CARDIOLOGY (2015)
by: N. V. Melnik
Published: (2018-01-01)

Implantable cardioverter-defibrillators in sudden cardiac death prevention: guidelines and clinical practice (literature review)
by: I. V. Talibullin, et al.
Published: (2022-04-01)

Validation of ACC/AHA and ESC Sudden Cardiac Death Risk Guidelines in Diverse Hypertrophic Cardiomyopathy Cohort: Stratification HCM Study
by: Murillo Oliveira Antunes, et al.
Published: (2024-12-01)

Risk stratification of sudden cardiac death in heart failure patients: is left ventricular ejection fraction alone sufficient?
by: N. N. Ilov, et al.
Published: (2021-02-01)

CURRENT RECOMMENDATIONS ON RISK STRATIFICATION AND SUDDEN CARDIAC DEATH PREVENTION IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY (BASED ON THE 2011 RECOMMENDATIONS BY THE AMERICAN COLLEGE OF CARDIOLOGY / AMERICAN HEART ASSOCIATION)
by: E. V. Privalova, et al.
Published: (2013-02-01)

Ventricular arrhythmias. Ventricular tachycardias and sudden cardiac death. 2020 Clinical guidelines
by: D. S. Lebedev, et al.
Published: (2021-08-01)

Return‐to‐play in athletes with transvenous and subcutaneous implantable cardiac defibrillator: A meta‐analysis
by: Rifqi Rizkani Eri, et al.
Published: (2025-08-01)

Polymorphisms in the GNAS Gene as Predictors of Ventricular Tachyarrhythmias and Sudden Cardiac Death: Results From the DISCOVERY Trial and Oregon Sudden Unexpected Death Study
by: Heinrich Wieneke, et al.
Published: (2016-12-01)

The triglyceride-glucose index, ventricular arrhythmias and major cardiovascular events in patients at high risk of sudden cardiac death
by: Yuan Gao, et al.
Published: (2024-10-01)

Analysis of arrhythmic episodes in patients with implanted cardioverter defibrillators and a high risk of sudden cardiac death
by: A. S. Postol, et al.
Published: (2019-11-01)

Safety and Tolerability of Implanted Subcutaneous Cardioverter-Defibrillator Systems
by: A. V. Vereshchagina, et al.
Published: (2022-09-01)

Resting heart rate assessed within clinical practice demonstrates no prognostic relevance for defibrillator recipients in the German DEVICE registry
by: Fares-Alexander Alken, et al.
Published: (2024-11-01)

Navigating the Uncommon: Case Report of Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) Successfully Managed with Implantable Cardioverter Defibrillator (ICD)
by: Sidhi Laksono Purwowiyoto, et al.
Published: (2024-10-01)

CLINICAL OPINION: BRUGADA SYNDROME AND SICK SYNUS SYNDROME — CASE WHICH WE MEET IN OUR PRACTICE
by: Tomislav Kostic, et al.
Published: (2014-01-01)

Importance of blood biomarker determination in the selection of patients with heart failure for cardioverterdefibrillator implantation
by: N. N. Ilov, et al.
Published: (2023-11-01)

Brugada Syndrome and Exercise: Is It Time for a Paradigm Change?
by: Carolina Miguel Gonçalves, et al.
Published: (2025-03-01)

Fever as a Catalyst for Life‐Threatening Arrhythmias in Brugada Syndrome: A Rare Case of Brugada Syndrome Unmasked in a Young Male
by: Ibrahim Khalil, et al.
Published: (2025-07-01)

Clinical characteristics of various arrhythmogenic cardiomyopathy phenotypes in the pediatric population: a systematic review and meta-analysis
by: D. Yu. Alekseeva, et al.
Published: (2022-12-01)

Subcutaneous cardioverter-defibrillator, patient selection, implantation, postoperative management in the Krasnoyarsk
by: A. V. Prokopenko, et al.
Published: (2022-09-01)

Short QT interval syndrome
by: I. G. Fomina, et al.
Published: (1970-01-01)

Comparative analysis of implantable cardioverter-defibrillator efficacy in ischemic and non-ischemic cardiomyopathy in patients with heart failure
by: Emre Demir, et al.
Published: (2025-07-01)

Biventricular hypertrophic cardiomyopathy with ACTC1 and LDB3 mutations, results of primary prevention of sudden cardiac death: а case report
by: V. N. Larina, et al.
Published: (2025-05-01)

Implantable cardioverter defibrillator - powerful weapon in primary and secondary prevention of sudden cardiac death
by: Kostić Tomislav, et al.
Published: (2019-01-01)

Clinical and anamnestic predictors of poor long-term prognosis in patients with chronic heart failure and implanted cardioverter-defibrillator
by: Nataliya B. Lebedeva, et al.
Published: (2025-01-01)

Cost-effectiveness and budget impact analyses of using implantable cardioverter-defibrillators in the Russian Federation
by: T. O. Bessonova, et al.
Published: (2022-04-01)

Non-compaction cardiomyopathy: clinical forms, outcomes and survival in a cohort of belarusian patients
by: S. M. Komissarova, et al.
Published: (2022-05-01)

Depression and Implantable Cardioverter‐Defibrillator Implantation in Black Patients at Risk for Sudden Cardiac Death
by: Brian C. Boursiquot, et al.
Published: (2024-07-01)

The Advances in Diagnosis and Treatment of Brugada Syndrome: A Comprehensive Review
by: Bartosz Szepietowski, et al.
Published: (2025-07-01)

Benefit of implantable cardioverter defibrillator use in Japanese patients based on modified MADIT‐ICD benefit score
by: Toshinori Chiba, et al.
Published: (2025-02-01)

Factors associated with the risk of progression and decompensation of heart failure in patients with an implantable cardioverter-defibrillator
by: N. B. Lebedeva, et al.
Published: (2024-04-01)

External validation of a multivariate model for predicting the risk of death in patients with chronic heart failure and an implantable cardioverter – defibrillator
by: N. B. Lebedeva, et al.
Published: (2024-07-01)

2015 ESC GUIDELINES FOR THE MANAGEMENT OF PATIENTS WITH VENTRICULAR ARRHYTHMIAS AND THE PREVENTION OF SUDDEN CARDIAC DEATH
by: Priori G. Silvia, et al.
Published: (2016-07-01)

Management of Gunshot Injury Involving Cardiac Implantable Electronic Device
by: Saad A. Ali, DO, et al.
Published: (2025-07-01)

Battery Longevity in Modern Implantable Cardioverter‐Defibrillators and Cardiac Resynchronization Therapy‐Defibrillators
by: Kotaro Nishino, et al.
Published: (2025-08-01)

Incidence, Predictors, and Outcomes of Implantable Cardioverter‐Defibrillator Discharge Among People Living With HIV
by: Raza M. Alvi, et al.
Published: (2018-09-01)

The role of cardiac MRI in risk stratification for sudden cardiac death in patients with hypertrophic cardiomyopathy
by: M. S. Ishchenko, et al.
Published: (2024-05-01)

Clinical outcomes during and after wearable cardioverter defibrillator use in Japanese patients with heart failure: A single‐center experience
by: Noriko Kikuchi, et al.
Published: (2024-12-01)

Modern views on myocardial electric instability correction and prognosis improvement in coronary heart disease patients
by: V. V. Popov, et al.
Published: (2007-06-01)